A randomized crossover trial of IV fluid replacement versus no fluid replacement in autologous blood donors with cardiovascular disease

Transfusion

Volumn 42, Issue 2, 2002, Pages 226-231

  Kasper, Stefan Mario ^a,b   Weimbs, Gregor ^a,b   Sabatowski, Rainer ^a,b   Wassmer, Gernot ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Municipal Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FLUID THERAPY; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD PRESSURE; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; FLUID THERAPY; HEMATOCRIT; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036480931     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00031.x     Document Type: Article

References (17)

1. 1 Spiess BD, Sassetti R, McCarthy RJ, et al. Autologous blood donation: hemodynamics in a high‐risk patient population. Transfusion 1992 ; 32: 17 ‐ 22.
2. 2 Kasper SM, Dahlmann H, Mellinghoff H, et al. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial. Vox Sang 1998 ; 75: 26 ‐ 31.
3. 3 Guidelines for autologous transfusion. I. Pre‐operative autologous donation. British Committee for Standards in Haematology Blood Transfusion Task Force. Transfus Med 1993;3:307‐16.
4. 4 Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989 ; 262: 1963 ‐ 8.
5. 5 Howard MR, Chapman CE, Dunstan JA, et al. Regional transfusion centre preoperative autologous blood donation programme: the first two years. Br Med J 1992 ; 305: 1470 ‐ 3.
6. 6 Pinkerton PH. Autologous blood donation in support of cardiac surgery: a preliminary report on a hospital‐based autologous donor programme. Can J Anaesth 1994 ; 41: 1036 ‐ 40.
7. 7 Kwapisz MM, Dietrich G, Viehl H, Hempelmann G. [Risk factors and frequency of adverse effects during and after autologous blood donation] (Engl abstract). Anaesthesist 1998 ; 47: 644 ‐ 50.
8. 8 Singbartl G, Schleinzer W. Adverse events in autologous blood donation and plasmapheresis: a 6‐year analysis in 28,244 patients with 50,542 donations. Infusionsther Transfusionsmed 1999 ; 26: 272 ‐ 7.
9. 9 Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994 ; 50: 1029 ‐ 41.
10. 10 Lehmacher W. Analysis of the crossover design in the presence of residual effects. Stat Med 1991 ; 10: 891 ‐ 9.
11. 11 AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion 1991 ; 31: 513 ‐ 7.
12. 12 Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995 ; 35: 734 ‐ 7.
13. 13 Doenicke A, Grote B, Lorenz W. Blood and blood substitutes. Br J Anaesth 1977 ; 49: 681 ‐ 8.
14. 14 Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977 ; 1: 466 ‐ 9.
15. 15 Kaye AD, Grogono AW. Fluid and electrolyte physiology. In: Miller RD, ed. Anesthesia, 5th ed. Philadelphia: Churchill Livingstone, 2000: 1586 ‐ 612.
16. 16 Goodnough LT, Monk TG. Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction. Am J Med 1996 ; 101 (Suppl 2a): 33S ‐ 7S.
17. 17 Gravenstein JS, Paulus DA. Clinical monitoring practice. 2nd ed. Philadelphia: JB Lippincott, 1987.